> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# First At Home Covid Test Gets EUA
- URL: https://www.fdaweb.com/first-at-home-covid-test-gets-eua/
- Published: 2020-11-18T12:00:00.000Z
- Updated: 2026-09-14T16:36:59.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148119

FDA has granted Lucira Health an Emergency Use Authorization for the first prescription molecular diagnostic test for Covid-19 that can be performed entirely at home. The Covid-19 All-In-One Test Kit can produce a positive or negative result at home within 30 minutes. The authorization was based on clinical trial data showing 100% of patients were successfully able to perform the Lucira test in about two minutes, the company says, adding that it will be broadly available by early spring 2021.

The test kit requires users to swab each nostril five times, according to Lucira. The swab is then stirred in the sample vial, and then pressed down in the test unit to start the test. A “ready” light will blink until a “positive” or “negative” green light is illuminated within 30 minutes.

The single-use device has been developed over five years, initially as a flu test kit, that patients would eventually be able to purchase from local drug stores. When the pandemic began early this year, Lucira redirected its efforts to Covid-19.